Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 1,359 | 2,206 | 2,350 | 2,445 | 2,001 |
| Cost of Goods | 584 | 598 | 725 | 930 | 919 |
| Gross Profit | 775 | 1,608 | 1,625 | 1,515 | 1,082 |
| Operating Expenses | 11,402 | 11,942 | 11,907 | 12,440 | 16,367 |
| Operating Income | -10,043 | -9,736 | -9,557 | -9,995 | -14,366 |
| Interest Expense | -2,104 | 480 | 1,717 | 74 | -1,677 |
| Other Income | 255 | 133 | 156 | 134 | 2,276 |
| Pre-tax Income | -7,684 | -10,083 | -11,118 | -9,935 | -10,413 |
| Net Income Continuous | -7,684 | -10,083 | -11,118 | -9,935 | -10,413 |
| Net Income | $-7,684 | $-10,083 | $-11,118 | $-9,935 | $-10,413 |
| EPS Basic Total Ops | -300.00 | -400.00 | -500.00 | -500.00 | -600.00 |
| EPS Basic Continuous Ops | -263.02 | -429.14 | -520.90 | -466.01 | -527.97 |
| EPS Diluted Total Ops | -300.00 | -400.00 | -500.00 | -500.00 | -600.00 |
| EPS Diluted Continuous Ops | -263.02 | -429.14 | -520.90 | -466.01 | -527.97 |
| EBITDA(a) | $-10,020 | $-9,714 | $-9,534 | $-9,973 | $-14,343 |